Interstitial Pneumonitis Associated With EGFR-TKI and Combined With PD-1/PD-L1

Conditions

• Non-Small Cell Lung Cancer (NSCLC)

Interventions

• DRUG: EGFR-TKI
• DRUG: PD-1/PD-L1 inhibitor
• DRUG: EGFR-TKI combined with PD-1/PD-L1

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology